Cuban drug Heberprot-P authorized for medical trials in the US
Havana, May 5.- The authorization for the Cuban-made injectable drug Heberprot-P to begin phase three of clinical trials in the United States is a new achievement by Cuban scientists and researchers from the biotechnological and pharmaceutical industry.
Read More